Spectrum Asset Management (California)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$522K Buy
18,597
+199
+1% +$5.3K 0.17% 72
2025
Q4
$458K Buy
18,398
+586
+3% +$14.8K 0.15% 74
2025
Q3
$454K Buy
17,812
+133
+0.8% +$3.28K 0.16% 76
2025
Q2
$429K Buy
17,679
+619
+4% +$14.4K 0.19% 72
2025
Q1
$432K Buy
17,060
+261
+2% +$6.83K 0.19% 61
2024
Q4
$446K Buy
16,799
+459
+3% +$12.4K 0.2% 71
2024
Q3
$473K Buy
16,340
+1,512
+10% +$44.1K 0.2% 67
2024
Q2
$415K Buy
14,828
+228
+2% +$6.28K 0.19% 67
2024
Q1
$405K Buy
+14,600
New +$405K 0.17% 70
2023
Q4
Sell
-7,040
Closed -$234K 99
2023
Q3
$234K Hold
7,040
0.12% 80
2023
Q2
$258K Hold
7,040
0.13% 74
2023
Q1
$287K Hold
7,040
0.14% 73
2022
Q4
$361K Sell
7,040
-125
-2% -$5.99K 0.17% 68
2022
Q3
$313K Buy
7,165
+177
+3% +$8.6K 0.16% 68
2022
Q2
$366K Sell
6,988
-155
-2% -$7.9K 0.18% 68
2022
Q1
$370K Hold
7,143
0.15% 82
2021
Q4
$422K Sell
7,143
-32
-0.4% -$1.58K 0.12% 93
2021
Q3
$309K Hold
7,175
0.1% 98
2021
Q2
$281K Hold
7,175
0.08% 104
2021
Q1
$260K Buy
7,175
+155
+2% +$5.5K 0.08% 109
2020
Q4
$258K Sell
7,020
-674
-9% -$24.7K 0.09% 94
2020
Q3
$268K Sell
7,694
-53
-0.7% -$1.86K 0.11% 87
2020
Q2
$240K Hold
7,747
0.12% 80
2020
Q1
$240K Sell
7,747
-43,700
-85% -$1.49M 0.23% 70
2019
Q4
$1.91M Sell
51,447
-1,501
-3% -$53.5K 1.05% 31
2019
Q3
$1.8M Hold
52,948
1.16% 26
2019
Q2
$2.18M Sell
52,948
-42
-0.1% -$1.67K 1.37% 20
2019
Q1
$2.13M Buy
52,990
+211
+0.4% +$8.45K 1.44% 17
2018
Q4
$2.19M Sell
52,779
-212
-0.4% -$8.8K 1.73% 13
2018
Q3
$2.22M Buy
52,991
+33,797
+176% +$1.3M 1.32% 15
2018
Q2
$661K Sell
19,194
-1,413
-7% -$48.3K 0.59% 37
2018
Q1
$716K Buy
20,607
+1,370
+7% +$47.1K 0.63% 38
2017
Q4
$661K Sell
19,237
-264
-1% -$9K 0.51% 42
2017
Q3
$661K Buy
19,501
+401
+2% +$12.9K 0.57% 36
2017
Q2
$609K Hold
19,100
0.56% 38
2017
Q1
$620K Buy
19,100
+1,476
+8% +$46.5K 0.57% 41
2016
Q4
$543K Buy
17,624
+3,267
+23% +$99.7K 0.53% 43
2016
Q3
$461K Hold
14,357
0.5% 34
2016
Q2
$480K Buy
14,357
+6
+0% +$191 0.57% 31
2016
Q1
$404K Hold
14,351
0.51% 32
2015
Q4
$440K Hold
14,351
0.5% 42
2015
Q3
$428K Hold
14,351
0.5% 38
2015
Q2
$457K Sell
14,351
-316
-2% -$10.3K 0.39% 48
2015
Q1
$484K Hold
14,667
0.43% 41
2014
Q4
$433K Buy
+14,667
New +$421K 0.36% 47

Other funds holding PFE

Spectrum Asset Management (California)'s PFE Position: Q1 2026 in Review

Spectrum Asset Management (California) increased its Pfizer (PFE) stake by 1.1% in Q1 2026, buying an estimated $5.3K and bringing the position to 18,597 shares worth $522K. The position accounts for 0.17% of the portfolio, ranked #72.

Spectrum Asset Management (California) first reported a position in PFE in Q4 2014 and has held it in 45 quarters since. The position peaked at $2.22M in Q3 2018. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Spectrum Asset Management (California) held 18,597 shares of Pfizer worth $522K as of Q1 2026.
  • Spectrum Asset Management (California) bought 199 Pfizer shares in Q1 2026, an estimated $5.3K.
  • Pfizer made up 0.17% of Spectrum Asset Management (California)'s portfolio in Q1 2026, its #72 holding.
  • Spectrum Asset Management (California) first reported a position in Pfizer in Q4 2014 and has held it in 45 quarters since.
  • Spectrum Asset Management (California)'s Pfizer position peaked at $2.22M in Q3 2018.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Spectrum Asset Management (California)'s 13F filing for Q1 2026, filed 22 Apr 2026.